CIHR Catalyst Grant: Strategy for Patient-Oriented Research (SPOR) Innovative Clinical Trials (iCT)

Maximum Value


Sponsor Deadline

July 19, 2023

UBCO RPIF Deadline

July 14, 2023 at 12:00 PM

NOI/LOI Deadline


UBCO E-submission Deadline


Program Description

The CIHR Catalyst Grant: SPOR Innovative Clinical Trials (iCT) aims to provide seed funding for the development of research collaborations across disciplines, including collaborations with People with Lived Experience (PWLE), and to develop novel research perspectives in early research stages in preparation for larger Strategy for Patient-Oriented Research (SPOR) Innovative Clinical Trials (iCT) multi-year grants or operating grant applications. Clinical trials are research studies involving human participants that evaluate the efficacy, safety, and effectiveness of clinical treatments and devices (e.g., drugs, lifestyle interventions, etc.) on health outcomes. Catalyst grants support developing new and transformative methods relevant to iCTs, with the potential to generate high impact results.


Full Program Terms

Proposal Development Support

For support in preparing a UBCO-led application, please get in touch with the contact below:

How to Apply

UBC Okanagan Submission Guidelines

Last updated: 2023-08-02 10:35